Latest News About - Hanta Fever
Tools
Wednesday, August 12, 2020
3:30:00 AM CEST
Language Selection
For any category/filter, users can choose:
- the language of the categorized news items (e.g. fr and de to display only those news items in French and German)
- the language of the user interface (e.g. it for Italian)
In Top Stories, the user can display the largest clusters of news items for one language only (e.g. en shows all clusters in English)
Country Selection
Users can choose:
- country mentioned in the news item (articles about a country)
- country in which the news item was published (articles from a country)
Languages 
Select your languages
Interface:
Most reported countries (24h)
AlertLevel (24h)
Previous 14 days average
Alert level:
high
medium
low
Extracted quotes
Eddie J Sullivan said: “This is a critical time in the global fight against COVID-19 and we believe that SAB-185, a fully-human polyclonal antibody, has the potential to serve as a differentiated therapeutic option. SAB-185 is supported by recently published preclinical data, which demonstrate that our novel immunotherapy platform can successfully neutralize mutated strains of viruses,” 
4-traders Tuesday, August 11, 2020 2:54:00 PM CEST
Eddie J Sullivan added: “We are determined to make a difference and help patients with our innovative new technology when it is needed most. We are proud to partner with JPEO and BARDA using science as the solution,” “Our team is working together with private, public, government, and academic collaborations at a diligent and accelerated pace to combat this global health crisis while providing a truly responsive model for future emerging diseases and biothreats”
4-traders Tuesday, August 11, 2020 2:54:00 PM CEST
Frank Hensel sagte: "Nach den jüngsten präklinischen Studien und angesichts der 2019 abgeschlossenen Phase I-Studie sind wir sehr zuversichtlich, dass ATR-002 den dringenden Bedarf für eine wirksame COVID-19-Therapie decken kann,"
onvista Tuesday, August 11, 2020 9:10:00 AM CEST
Rainer Lichtenberger sagte: "Mit der weiteren Unterstützung durch unsere erfahrenen Investoren konzentrieren wir uns nun auf den Start dieser wichtigen Phase II-Studie zur Behandlung von Patienten mit mittelschwer oder schwer verlaufenden COVID-19-Erkrankungen,"
onvista Tuesday, August 11, 2020 9:10:00 AM CEST
Frank Hensel said: "The recent preclinical studies as well as the Phase I study completed in 2019 give us great faith that ATR-002 will be able to fulfill the urgent need for an effective COVID-19 therapy,"
4-traders Tuesday, August 11, 2020 9:09:00 AM CEST
Rainer Lichtenberger said: "With such highly committed investors continuing to support our plans we will now focus on ramping-up this important pivotal Phase II trial to treat patients with moderate to severe COVID-19,"
4-traders Tuesday, August 11, 2020 9:09:00 AM CEST
Benjamin Neuman said: “We’re trying to sum up 30,000 nucleotides of information in as few words as possible,”
dallasnews Monday, August 10, 2020 8:36:00 AM CEST
Miguel Silva manifestó: “Se estaba vendiendo un cincuenta por ciento menos que antes de la pandemia, aunque de a poco levantaba; pero, ahora, con lo de los documentos pares e impares, se bajó todo de vuelta”
elcordillerano Friday, August 7, 2020 3:30:00 AM CEST
Fernando Goldbaum explica: “El coronavirus entra a la célula a través de una ‘proteína que actúa como llave’. Esta proteína hace que su membrana se una con la membrana del virus, introduciendo el material genético dentro de la célula y permitiendo así su propagación. Nosotros tomamos el pedacito de esta proteína que actúa como ‘llave’ y con ella inmunizamos a los caballos. De esta manera, los animales produjeron una cantidad muy grande de anticuerpos que, al unirse a la proteína, neutralizaron la capacidad del virus de entrar a las células. En definitiva, evitaron que el virus utilice esa ‘proteína llave’”
rionegro Tuesday, July 28, 2020 3:14:00 PM CEST
Howard Federoff said: “The National Training Center designation from NIH further establishes UCI as a leader in an area of research that is critically important for the public’s health,” “As a world-class research university, it’s in our DNA to continuously explore and to improve training”
news-uci Thursday, July 23, 2020 3:53:00 PM CEST
Alpesh Amin said: “Our center leaders bring several decades of their own experience in infectious disease research labs to the program, giving them an informed perspective on what world-class training should look like,”
news-uci Thursday, July 23, 2020 3:53:00 PM CEST
Neil Ferguson says: "Flu viruses incubate very rapidly – you tend to get symptoms two to three days after being infected, but coronaviruses take much longer,"
newsnow-co-uk Monday, July 20, 2020 5:56:00 AM CEST
Paula Daza explicó: "Cuando un médico, un profesional de salud, solicita un examen PCR, esa persona tiene que ser notificada a la plataforma de Epivigila. Eso lo hace el profesional de salud, él es quien le pide al laboratorio la información; lo que nosotros recibimos como Minsal, a través de Epivigila, es la información que nos testifican los médicos"
ElMercurioOnline Wednesday, July 15, 2020 1:06:00 AM CEST
Neil Ferguson says: "Flu viruses incubate very rapidly – you tend to get symptoms two to three days after being infected, but coronaviruses take much longer,"
telegraph Tuesday, July 14, 2020 7:21:00 AM CEST
Neil Ferguson says: "Flu viruses incubate very rapidly – you tend to get symptoms two to three days after being infected, but coronaviruses take much longer,"
telegraph Saturday, July 4, 2020 9:50:00 AM CEST
Most associated names
Daily number of articles in this category
Trend data not available for this selection.
Most active sources for this category
Contact: 